XBIO

Xenetic Biosciences, Inc.

Healthcare · Biotechnology

$78.11 sample

-0.93 (-1.18%) 1D

Market cap

$395.2B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$78.11 -5.89% 3M daily closessample

88.3678.11

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider buy: Chief Executive Officer
Sep 28INSInsider buy: Director
Sep 22INSInsider buy: General Counsel
Sep 17INSInsider sell: General Counsel
Sep 08INSInsider buy: EVP, Operations
Sep 01INSInsider sell: EVP, Operations
Aug 24INSInsider sell: Chief Financial Officer
Aug 17INSInsider buy: Chief Financial Officer

Sign up to see the real XBIO record →

Company facts

SEC EDGAR registration

Name: Xenetic Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in XBIO

sample

Insiders: 14 insider transactions over 90 days, net selling, $144.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 36 funds hold $8.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.0B +13.5% y/y

Q4 2024Q3 2026

Inventory$5.7B +10.4% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +13.0% y/y

Q4 2024Q3 2026

Total debt$11.4B +3.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $83.0B +8.8% 3M
Sample peer B: $141.8B +4.1% 3M
Sample peer C: $318.9B -3.4% 3M
Sample peer D: $252.0B -0.5% 3M
Sample peer E: $299.2B +14.3% 3M